+44 79 19 49 39 39 wilsonblaney@gmail.com

Novartis slammed for ‘alarmist’ ad for heart failure drug
The campaign, however, does not specifically mention Entresto, a Novartis drug that was approved last summer by US regulators to prevent heart failure, which is a common malady that afflicts about 5.1 million Americans. Advertising that discusses an …
Read more on STAT

 

Novartis revamps Alcon eyecare division
Novartis has set a deadline for its struggling eyecare business to return to growth by the end of this year or risk being jettisoned by the Swiss pharmaceuticals group. Joe Jimenez, chief executive, said he wanted to keep Alcon, which Novartis took …
Read more on Financial Times

 

The Motley Fool: Drug giant Novartis is poised for future profit
Click here to comment on this story ». Most recent Business. Front & Center: Sylvia Dunn adds the extra touch for home sales · The Motley Fool: Drug giant Novartis is poised for future profit · As REI thrives, does it have members or merely shoppers?
Read more on The Spokesman Review (registration)

 

Share Button